Alector logo
Alector
ALEC | NASDAQ
Chart Builder DCF Calculator
$2.56
-$0.01 (-0.39%)
At close: Nov 17, 2026, 4:00 PM ET
$2.50
-$0.06 (-2.27%)
After-hours: Nov 17, 2026, 7:30 PM ET

Alector Company Profile

Company profile explained

Company Profile

Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its treatment targets immune dysfunction as a root cause of multiple pathologies that are drivers of degenerative brain disorders. The company was founded by Asa Abeliovich, Errik B. Anderson, Tillman U. Gerngross, and Arnon Rosenthal in May 2013 and is headquartered in South San Francisco, CA.

Key Executives

Name Position
Arnon Rosenthal Co-Founder, Chief Executive Officer & Director
Caiyan Li Head of Clinical Development & Data Science
Clare Hunt Chief People & Places Officer
Danielle Pasqualone General Counsel
Eric Brown Director of Antibody Discovery & Protein Engineering
Hua Long DABT Senior VP & Head of Research
Katie Hogan Senior Director of Corporate Communication & Investor Relations
Neil Berkley CFO & Chief Business Officer

Latest SEC Filings

Date Type Title
Oct 26, 2026 SC 13G Statement of acquisition of beneficial ownership b...
Oct 23, 2026 SC 13G Statement of acquisition of beneficial ownership b...
Oct 16, 2026 424B5 Filing
Oct 16, 2026 8-K Current Report
Oct 16, 2026 FWP Filing
Oct 15, 2026 4 Filing
Oct 15, 2026 4 Filing
Oct 15, 2026 4 Filing
Oct 14, 2026 8-K Current Report
Oct 05, 2026 8-K Current Report
View All SEC Filings ➞
Alector
Alector logo
Country United States
IPO Date Feb 7, 2019
Industry Biotechnology
Sector Healthcare
Employees 103
CEO Arnon Rosenthal

Contact Details

131 Oyster Point Boulevard South San Francisco, California 94080 United States

Stock Details

Ticker Symbol ALEC
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001653087
CUSIP Number 014442107
ISIN Number US0144421072
SIC Code 2836

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.